Braidwell »

Dbv Technologies S A shares owned by Braidwell

Quarter-by-quarter ownership of Dbv Technologies S A shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Dbv Technologies S A

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies S A held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies S A by Braidwell

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.0M 2.4M 0.80

More positions owned by Braidwell

Guardant Health Note11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Novocure Note11/0 (Principal)
Nuvasive Note 0.375% 3/1 (Principal)
Neurocrine Biosciences (NBIX)
Cg Oncology (CGON)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Neogenomics Note 0.250% 1/1 (Principal)
Ironwood Pharmaceuticals Note 1.500% 6/1 (Principal)
Dexcom Note 0.375% 5/1 (Principal)
Guardant Health (GH)
Insulet Corp Note 0.375% 9/0 (Principal)
Legend Biotech Corp Sponsored Ads (LEGN)
Dexcom Note 0.250%11/1 (Principal)

View all positions for Braidwell

Top funds holding Dbv Technologies S A

Baker Bros. Advisors
Yiheng Capital
Braidwell
Point72 Asset Management
Morgan Stanley
Millennium Management
Nan Fung Group Holdings
Citadel Advisors
Hrt Financial
Landscape Capital Management
Cowen And Company
Geode Capital Management
Old Mission Capital
Rhumbline Advisers
Janney Montgomery Scott

View all funds holding Dbv Technologies S A